These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 26546465)

  • 1. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy.
    Kemp JA; Shim MS; Heo CY; Kwon YJ
    Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy.
    Hussain Z; Arooj M; Malik A; Hussain F; Safdar H; Khan S; Sohail M; Pandey M; Choudhury H; Ei Thu H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1015-1024. PubMed ID: 29873531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic nanomedicine by combined gene and photothermal therapy.
    Kim J; Kim J; Jeong C; Kim WJ
    Adv Drug Deliv Rev; 2016 Mar; 98():99-112. PubMed ID: 26748259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Carbon Nanomaterials for Cancer Phototherapy.
    Jiang BP; Zhou B; Lin Z; Liang H; Shen XC
    Chemistry; 2019 Mar; 25(16):3993-4004. PubMed ID: 30328167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
    Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
    Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterials for cancer therapy: current progress and perspectives.
    Cheng Z; Li M; Dey R; Chen Y
    J Hematol Oncol; 2021 May; 14(1):85. PubMed ID: 34059100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging advances in nanomedicine with engineered gold nanostructures.
    Webb JA; Bardhan R
    Nanoscale; 2014 Mar; 6(5):2502-30. PubMed ID: 24445488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer nanomedicine: from targeted delivery to combination therapy.
    Xu X; Ho W; Zhang X; Bertrand N; Farokhzad O
    Trends Mol Med; 2015 Apr; 21(4):223-32. PubMed ID: 25656384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomedical nanomaterials for imaging-guided cancer therapy.
    Huang Y; He S; Cao W; Cai K; Liang XJ
    Nanoscale; 2012 Oct; 4(20):6135-49. PubMed ID: 22929990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.
    Xie X; Zhang Y; Li F; Lv T; Li Z; Chen H; Jia L; Gao Y
    Curr Cancer Drug Targets; 2019; 19(4):257-276. PubMed ID: 29956629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared light-responsive nanomaterials for cancer theranostics.
    Kim H; Chung K; Lee S; Kim DH; Lee H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):23-45. PubMed ID: 25903643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.
    Markovsky E; Baabur-Cohen H; Satchi-Fainaro R
    J Control Release; 2014 Aug; 187():145-57. PubMed ID: 24862318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology applications in cancer.
    Nie S; Xing Y; Kim GJ; Simons JW
    Annu Rev Biomed Eng; 2007; 9():257-88. PubMed ID: 17439359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.